Drug Report History #274527
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that have changed between versions will be highlighted in yellow, and the changes will be clearly marked as updated.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow, and the change will be clearly marked as updated.
| Field | Version v10-EN | Version v4-EN |
|---|---|---|
| Language | English | English |
| Date Updated | 2026-02-27 (Updated) | 2026-01-13 |
| Drug Identification Number | 02392763 | 02392763 |
| Brand name | TRANEXAMIC ACID INJECTION | TRANEXAMIC ACID INJECTION |
| Common or Proper name | TRANEXAMIC ACID INJECTION 100MG/ML | TRANEXAMIC ACID INJECTION 100MG/ML |
| Company Name | OMEGA LABORATORIES LIMITED | OMEGA LABORATORIES LIMITED |
| Ingredients | TRANEXAMIC ACID | TRANEXAMIC ACID |
| Strength(s) | 100MG | 100MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
| Packaging size | 10 x 10 mL vial / fiole & 1 x 50mL vial / fiole (Updated) | 10 x 10 mL vial / fiole |
| Anatomical Therapeutical Chemical (ATC) code | B02AA | B02AA |
| Anatomical Therapeutical Chemical (ATC) description | ANTIFIBRINOLYTICS | ANTIFIBRINOLYTICS |
| Reason for shortage | Demand increase for the drug. | Demand increase for the drug. |
| Anticipated start date | ||
| Actual start date | 2025-12-17 | 2025-12-17 |
| Estimated end date | 2026-02-13 | 2026-02-13 |
| Actual end date | 2026-02-12 (Updated) | |
| Shortage status | Resolved (Updated) | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Stock available at CPDN | Stock available at CPDN |
| Health Canada comments |